Therapeutics / Research / Drugs / Biotech / BioTech / Drug / Cancer / Boston / Boston blog main / Boston top stories / National blog main / New York blog main / Abingworth / Alzheimer's disease / Atlas Venture / Autoimmune Disorders / Bristol-myers Squibb / cancer / clinical trials / deals / Fibrosis / IFM / IFM Therapeutics LLC / IFM Tre / Inflammation / investing / Life Sciences / metabolic disorders / Neurodegenerative Diseases / startups

Fresh Off Bristol Buyout, IFM Backers Raise $31M to Plot a Second Strike

Posted on: Jul 19, 2018   |   Posted by: Biotech Mag

Fresh Off Bristol Buyout, IFM Backers Raise $31M to Plot a Second Strike

Nearly one year ago, biotech startup IFM Therapeutics sold some of its assets to Bristol-Myers Squibb for $300 million. But IFM's founders stuck around to try to capitalize on...

Continue reading ...



Other Posts from Biotech Mag